Literature DB >> 28087922

Urogenital Tuberculosis.

André A Figueiredo1, Antônio M Lucon2, Miguel Srougi2.   

Abstract

Urogenital tuberculosis is the second most frequent form of extrapulmonary tuberculosis. Starting with a pulmonary focus, 2 to 20% of patients develop urogenital tuberculosis through hematogenous spread to the kidneys, prostate, and epididymis; through the descending collecting system to the ureters, bladder, and urethra; and through the ejaculatory ducts to the genital organs. Urogenital tuberculosis occurs at all age ranges, but it is predominant in males in their fourth and fifth decades. It is a serious, insidious disease, generally developing symptoms only at a late stage, which leads to a diagnostic delay with consequent urogenital organ destruction; there are reports of patients with renal failure as their initial clinical presentation. Although the condition has been long recognized by nephrologists, urologists, and infectious disease specialists, urogenital tuberculosis is still largely unknown. Even when suggestive findings such as hematuria, sterile pyuria, and recurrent urinary infections are present, we rarely remember this diagnostic possibility. Greater knowledge of the features of urogenital tuberculosis then becomes relevant and should emphasize the importance of an early diagnosis.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28087922     DOI: 10.1128/microbiolspec.TNMI7-0015-2016

Source DB:  PubMed          Journal:  Microbiol Spectr        ISSN: 2165-0497


  15 in total

1.  Obstructive uropathy as initial presentation of genitourinary tuberculosis and masquerading as a postsurgical complication.

Authors:  Grace Igiraneza; Theobald Hategekimana; Olivier M Manzi; Onyema Ogbuagu
Journal:  BMJ Case Rep       Date:  2017-10-15

2.  All in the Stream.

Authors:  Benjamin Mba; Brian P Lucas; Nathan Houchens; Jennifer Marie Seares; Udit Joshi
Journal:  J Hosp Med       Date:  2019-09-18       Impact factor: 2.960

3.  Challenges in urogenital tuberculosis.

Authors:  Ekaterina Kulchavenya; Denis Kholtobin; Sergey Shevchenko
Journal:  World J Urol       Date:  2019-04-17       Impact factor: 4.226

4.  Diagnostic nomogram to differentiate between epididymal tuberculosis and bacterial epididymitis.

Authors:  Pengju Liu; Guofeng Cai; Hai Gu; Yong Qin
Journal:  Infection       Date:  2022-09-16       Impact factor: 7.455

Review 5.  An atlas overview of characteristic features of tuberculosis that may be encountered at autopsy.

Authors:  Lilli Stephenson; Roger W Byard
Journal:  Forensic Sci Med Pathol       Date:  2019-08-30       Impact factor: 2.007

6.  Tuberculosis Relapse in the Epididymis After the Completion of Nine Months of Anti-Tuberculosis Chemotherapy in a Patient with Poorly Controlled Diabetes Mellitus.

Authors:  Chikako Ichikawa; Sho Tanaka; Masahiro Takubo; Masaru Kushimoto; Jin Ikeda; Katsuhiko Ogawa; Ichiro Tsujino; Yutaka Suzuki; Masanori Abe; Hisamitsu Ishihara; Midori Fujishiro
Journal:  Ther Clin Risk Manag       Date:  2021-05-25       Impact factor: 2.423

7.  Urogenital tuberculosis, the cause of ineffective antibacterial therapy for urinary tract infections.

Authors:  Ekaterina Kulchavenya; Andrey Cherednichenko
Journal:  Ther Adv Urol       Date:  2017-12-22

8.  Multicentre evaluation of Xpert MTB/RIF assay in detecting urinary tract tuberculosis with urine samples.

Authors:  Yu Chen; Peng Wu; Liang Fu; Yu-Hong Liu; Yao Zhang; Yanping Zhao
Journal:  Sci Rep       Date:  2019-07-30       Impact factor: 4.379

9.  Chronic kidney disease with genitourinary tuberculosis: old disease but ongoing complication.

Authors:  Eun Jin Kim; Woonji Lee; Woo Yong Jeong; Hen Choi; In Young Jung; Jin Young Ahn; Su Jin Jeong; Nam Su Ku; Jun Yong Choi; Young Hwa Choi; Young Goo Song; June Myung Kim
Journal:  BMC Nephrol       Date:  2018-08-02       Impact factor: 2.388

10.  Case report of pelvic tuberculosis resulting in Asherman's syndrome and infertility.

Authors:  Mary Louise Fowler; Shruthi Mahalingaiah
Journal:  Fertil Res Pract       Date:  2019-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.